Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:50 PM
NCT ID:
NCT04109404
Eligibility Criteria:
Inclusion Criteria:
* minimum 18 years
* medical follow up in CHRU of Brest
* treated by CYPROTERONE ACETATE and/or CHLORMADINONE ACETATE NOMEGESTROL ACETATE, PROGESTERONE , DYDROGESTERONE PROMEGESTONE , NORETHISTERONE, LEVONORGESTREL , oestroprogestogenic contraception
* meningioma after treatement by progestin or CYPROTERONE ACETATE
Exclusion Criteria:
* history ofbreast cancer
* history of cerebral radiotherapy
* history of neurofibromatosis
* meningioma before treatement by progestin or CYPROTERONE ACETATE
* minor patient
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04109404
Study Brief:
Protocol Section:
NCT04109404